This company scores below average, with supportive analyst views and a healthy balance sheet, although its current valuation deserves attention.
Quant Score on a 1–100 scale, computed Oct 29, 2:04 PM EDT from the data shown on this page. It describes the company’s current profile — it is not a price prediction or a recommendation. How it’s calculated
Tap any area to see the numbers it is based on.
Is this a profitable, well-run business?
Weak. Strongest signal: free cash flow / operating cash flow at 340%. Weakest: return on equity (ttm) at 1.0%.
| Input | Value | Points /10 |
|---|---|---|
| Return on equity (TTM) | 1.0% | 0.0 |
| Return on invested capital (TTM) | 0.2% | 0.0 |
| Operating margin (TTM) | 3.1% | 0.0 |
| Net margin (TTM) | 3.2% | 0.5 |
| Free cash flow / operating cash flow | 340% | 10.0 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
The case for, the case against, and what to watch.
Is the business growing, profitable and able to carry its debt?
Is the stock reasonably priced?
The stock looks expensive relative to its earnings and cash flow, so expectations are high.
See how it stacks up on quality, growth, valuation, risk and momentum.
Is this a financially healthy business?
Strong. Strongest signal: altman z-score at 14.67. Weakest: interest coverage at 4.9x.
| Input | Value | Points /10 |
|---|---|---|
| Piotroski F-Score | 4/9 | 3.3 |
| Altman Z-Score | 14.67 | 10.0 |
| Debt / Equity | 0.10 | 10.0 |
| Current ratio | 4.8x | 10.0 |
| Interest coverage | 4.9x | 1.6 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
Is the stock expensive?
Expensive.
| Input | Value | Points /10 |
|---|---|---|
| P/E (TTM) | 2179.1x | 0.0 |
| PEG | 10.18 | 0.0 |
| Price / FCF | -174.5x | n/a |
| EV / EBITDA | 210.3x | 0.0 |
| DCF upside | -110.9% | 0.0 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
Is the company growing?
Slow or shrinking. Strongest signal: forward revenue growth at 150.4%. Weakest: revenue growth (fy) at -11.1%.
| Input | Value | Points /10 |
|---|---|---|
| Revenue growth (FY) | -11.1% | 0.0 |
| Net income growth (FY) | -82.9% | 0.0 |
| Revenue CAGR (3Y) | -14.5% | 0.0 |
| Forward revenue growth | 150.4% | 10.0 |
| Gross margin | 32.2% | 2.4 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
Is the stock price showing strength?
Weak. Strongest signal: rsi (14) at 37.2. Weakest: macd histogram at -2.13.
| Input | Value | Points /10 |
|---|---|---|
| Trend alignment (50/200 SMA) | 1/3 | 3.3 |
| RSI (14) | 37.2 | 6.0 |
| MACD histogram | -2.13 | 2.0 |
| Signal consensus | Strong Sell | 2.5 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
What do professional analysts think?
Very positive. Strongest signal: target upside at 91.1%.
| Input | Value | Points /10 |
|---|---|---|
| Analyst buy share | 73% | 7.1 |
| Target upside | 91.1% | 10.0 |
| 90-day rating revisions | 1↑ / 0↓ | 10.0 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
What could go wrong?
High risk. Strongest signal: net debt / ebitda at -22.3x. Weakest: price volatility (1y, annualised) at 150%.
| Input | Value | Points /10 |
|---|---|---|
| Beta (vs. market) | 1.86 | 1.0 |
| Price volatility (1Y, annualised) | 150% | 0.0 |
| Largest 1Y drawdown | -74% | 0.0 |
| Net debt / EBITDA | -22.3x | 10.0 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
A formula-based estimate from projected cash flows. Small changes in assumptions move it a lot — treat it as one input, not a price the stock will reach.
Range $90.00–$125.00. Analysts' 12-month opinions; they are frequently wrong and are not our forecast.
Source: Financial Modeling Prep · P/E trailing twelve months; history from annual filings · USD · data as of Oct 24, 2026
Revenue is what customers paid the company. Over 4 years it has shrunk about 10% a year on average.
Net income is the profit left after all costs and taxes. Over 4 years it has shrunk about NaN% a year on average.
Cash the business generates after investing in itself — what can fund dividends, buybacks or growth. It has been negative over the period shown.
Share of sales left after the direct cost of products.
Share of sales left after running the business.
Share of sales kept as profit.
Debt is low compared with shareholders' equity.
Returns on invested money are low.
Profits cover interest payments comfortably.
Source: Financial Modeling Prep · annual filings FY2021–FY2025; margins and ratios trailing twelve months · USD · data as of Oct 24, 2026
